Cancer stem cells: Models and concepts

被引:965
作者
Dalerba, Piero [1 ]
Cho, Robert W. [1 ]
Clarke, Michael F. [1 ]
机构
[1] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA
来源
ANNUAL REVIEW OF MEDICINE | 2007年 / 58卷
关键词
self-renewal; aberrant differentiation; functional heterogeneity of tumor tissues; targeting of antitumor treatments;
D O I
10.1146/annurev.med.58.062105.204854
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although monoclonal in origin, most tumors appear to contain a heterogeneous population of cancer cells. This observation is traditionally explained by postulating variations in tumor microenvironment and coexistence of multiple genetic subclones, created by progressive and divergent accumulation ofindependent somatic mutations. An additional explanation, however, envisages human tumors not as mere monoclonal expansions of transformed cells, but rather as complex tridimensional tissues where cancer cells become functionally heterogeneous as a result of differentiation. According to this second scenario, tumors act as caricatures of their corresponding normal.. tissues,and are sustained in their growth by a pathological counterpart of normal adult stem cells, cancer stem cells. This model, first developed in human myeloid leukemias, is today being extended to solid tumors, such as breast and brain cancer. We review the biological basis and the therapeutic implications of the stem cell model of cancer.
引用
收藏
页码:267 / 284
页数:18
相关论文
共 94 条
  • [41] SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
    Kiel, MJ
    Yilmaz, ÖH
    Iwashita, T
    Yilmaz, OH
    Terhorst, C
    Morrison, SJ
    [J]. CELL, 2005, 121 (07) : 1109 - 1121
  • [42] Identification of bronchioalveolar stem cells in normal lung and lung cancer
    Kim, CFB
    Jackson, EL
    Woolfenden, AE
    Lawrence, S
    Babar, I
    Vogel, S
    Crowley, D
    Bronson, RT
    Jacks, T
    [J]. CELL, 2005, 121 (06) : 823 - 835
  • [43] Biology of hematopoietic stem cells and progenitors: Implications for clinical application
    Kondo, M
    Wagers, AJ
    Manz, MG
    Prohaska, SS
    Scherer, DC
    Beilhack, GE
    Shizuru, JA
    Weissman, IL
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 : 759 - 806
  • [44] Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
    Kroon, E
    Krosl, J
    Thorsteinsdottir, U
    Baban, S
    Buchberg, AM
    Sauvageau, G
    [J]. EMBO JOURNAL, 1998, 17 (13) : 3714 - 3725
  • [45] Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy?
    Kyo, S
    Inoue, M
    [J]. ONCOGENE, 2002, 21 (04) : 688 - 697
  • [46] A CELL INITIATING HUMAN ACUTE MYELOID-LEUKEMIA AFTER TRANSPLANTATION INTO SCID MICE
    LAPIDOT, T
    SIRARD, C
    VORMOOR, J
    MURDOCH, B
    HOANG, T
    CACERESCORTES, J
    MINDEN, M
    PATERSON, B
    CALIGIURI, MA
    DICK, JE
    [J]. NATURE, 1994, 367 (6464) : 645 - 648
  • [47] Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
    Lessard, J
    Sauvageau, G
    [J]. NATURE, 2003, 423 (6937) : 255 - 260
  • [48] Stage-specific expression of Polycomb group genes in human bone marrow cells
    Lessard, J
    Baban, S
    Sauvageau, G
    [J]. BLOOD, 1998, 91 (04) : 1216 - 1224
  • [49] Evolution of intratumoral genetic heterogeneity during colorectal cancer progression
    Losi, L
    Baisse, B
    Bouzourene, H
    Benhattar, J
    [J]. CARCINOGENESIS, 2005, 26 (05) : 916 - 922
  • [50] STABILITY OF K-RAS MUTATIONS THROUGHOUT THE NATURAL-HISTORY OF HUMAN COLORECTAL-CANCER
    LOSI, L
    BENHATTAR, J
    COSTA, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (6-7) : 1115 - 1120